Thrombin activity associated with neuronal damage during acute focal Ischemia

Journal of Neuroscience

Volumn 32, Issue 22, 2012, Pages 7622-7631

  Chen, Bo ^a,c   Friedman, Beth ^b   Whitney, Michael A ^b   van Winkle, Jessica A ^a   Le, I Farn ^a   Olson, Emilia S ^b   Cheng, Qun ^c   Pereira, Benedict ^a   Zhao, Lifu ^a   Tsien, Roger Y ^b,d   Lyden, Patrick D ^a,c  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Departments of Chemistry and Biochemistry   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGATROBAN; CELL PENETRATING PEPTIDE; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN ISCHEMIA; CELL DAMAGE; COGNITIVE DEFECT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LATENT PERIOD; LEARNING; MALE; MEMORY; MIDDLE CEREBRAL ARTERY; NERVE INJURY; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; STROKE; VASCULAR DISEASE; WESTERN BLOTTING;

AMINO ACIDS; ANALYSIS OF VARIANCE; ANIMALS; ANTITHROMBINS; AVOIDANCE LEARNING; BRAIN INJURIES; CELL DEATH; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; FACTOR X; FIBRINOLYSIN; GENE EXPRESSION REGULATION; IN SITU NICK-END LABELING; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MAZE LEARNING; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; PIPECOLIC ACIDS; PYRROLES; RATS; REACTION TIME; RECEPTOR, PAR-1; THROMBIN; TIME FACTORS;

EID: 84861636758     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0369-12.2012     Document Type: Article

References (48)

1. Arai T, Miklossy J, Klegeris A, Guo JP, McGeer PL (2006) Thrombin and prothrombin are expressed by neurons and glial cells and accumulate in neurofibrillary tangles in Alzheimer disease brain. J Neuropathol Exp Neurol 65:19-25.
2. Barreto AD, Alexandrov AV, Lyden P, Lee J, Martin-Schild S, Shen L, Wu TC, Sisson A, Pandurengan R, Chen Z, Rahbar MH, Balucani C, Barlinn K, Sugg RM, Garami Z, Tsivgoulis G, Gonzales NR, Savitz SI, Mikulik R, Demchuk AM, Grotta JC (2012) The argatroban and tissue-type plas-minogen activator stroke study: final results of a pilot safety study. Stroke 43:770-775.
3. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H (1986) Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17:472-476.
4. Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, Zlokovic BV (2010) Pericytes control key neurovascular functions and neuronal phe-notype in the adult brain and during brain aging. Neuron 68:409-427.
5. Chen B, Friedman B, Cheng Q, Tsai P, Schim E, Kleinfeld D, Lyden PD (2009) Severe blood-brain barrier disruption and surrounding tissue injury. Stroke 40:e666-e674.
6. Chen B, Cheng Q, Yang K, Lyden PD (2010) Thrombin mediates severe neurovascular injury during ischemia. Stroke 41:2348-2352.
7. Cheng T, Liu D, Griffin JH, Fernández JA, Castellino F, Rosen ED, Fukudome K, Zlokovic BV (2003) Activated protein C blocks p53-mediated apo-ptosis in ischemic human brain endothelium and is neuroprotective. Nat Med 9:338-342.
8. Choi SH, Lee DY, Kim SU, Jin BK (2005) Thrombin-induced oxidative stress contributes to the death of hippocampal neurons in vivo: role of microglial NADPH oxidase. J Neurosci 25:4082-4090.
9. Coughlin SR (2000) Thrombin signalling and protease-activated receptors. Nature 407:258-264.
10. de Garavilla L, Vergnolle N, Young SH, Ennes H, Steinhoff M, Ossovskaya VS, D'Andrea MR, Mayer EA, Wallace JL, Hollenberg MD, Andrade-Gordon P, Bunnett NW (2001) Agonists of proteinase-activated receptor 1 induce plasma extravasation by a neurogenic mechanism. Br J Pharmacol 133:975-987.
11. Dihanich M, Kaser M, Reinhard E, Cunningham D, Monard D (1991) Pro-thrombin mRNA is expressed by cells of the nervous system. Neuron 6:575-581.
12. Dömötör E, Benzakour O, Griffin JH, Yule D, Fukudome K, Zlokovic BV (2003) Activated protein C alters cytosolic calcium flux in human brain endothelium via binding to endothelial protein C receptor and activation of protease activated receptor-1. Blood 101:4797-4801.
13. Donovan FM, Pike CJ, Cotman CW, Cunningham DD (1997) Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J Neurosci 17:5316-5326.
14. Friedman B, Schachtrup C, Tsai PS, Shih AY, Akassoglou K, Kleinfeld D, Lyden PD (2009) Acute vascular disruption and aquaporin 4 loss after stroke. Stroke 40:2182-2190.
15. Giacaman RA, Asrani AC, Ross KF, Herzberg MC (2009) Cleavage of protease-activated receptorsonanimmortalized oral epithelial cell line by Porphyromonas gingivalis gingipains. Microbiology 155:3238-3246.
16. Gingrich MB, Junge CE, Lyuboslavsky P, Traynelis SF (2000) Potentiation of NMDA receptor function by the serine protease thrombin. J Neurosci 20:4582-4595.
17. Grammas P, Ottman T, Reimann-Philipp U, Larabee J, Weigel PH (2004) Injured brain endothelial cells release neurotoxic thrombin. J Alzheimers Dis 6:275-281.
18. Griffin CT, Srinivasan Y, Zheng YW, Huang W, Coughlin SR (2001) A role for thrombin receptor signaling in endothelial cells during embryonic development. Science 293:1666-1670.
19. Haralabopoulos GC, Grant DS, Kleinman HK, Maragoudakis ME (1997) Thrombin promotes endothelial cell alignment in Matrigel in vitro and angiogenesis in vivo. Am J Physiol 273:C239-C245.
20. Hoxie JA, Ahuja M, Belmonte E, Pizarro S, Parton R, Brass LF (1993) Inter-nalization and recycling of activated thrombin receptors. J Biol Chem 268:13756-13763.
21. Ishihara H, Connolly AJ, Zeng D, Kahn ML, Zheng YW, Timmons C, Tram T, Coughlin SR (1997) Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386:502-506.
22. Jiang T, Olson ES, Nguyen QT, Roy M, Jennings PA, Tsien RY (2004) Tumor imaging by means of proteolytic activation of cell-penetrating pep-tides. Proc Natl Acad Sci U S A 101:17867-17872.
23. Junge CE, Sugawara T, Mannaioni G, Alagarsamy S, Conn PJ, Brat DJ, Chan PH, Traynelis SF (2003) The contribution of protease-activated recep-tor1toneuronal damage caused bytransient focal cerebral ischemia. Proc Natl Acad Sci U S A 100:13019-13024.
24. Kameda K, Kikkawa Y, Hirano M, Matsuo S, Sasaki T, Hirano K (2012) Combined argatroban and anti-oxidative agents prevents increased vascular contractilitytothrombin and other ligands after subarachnoid hemorrhage. Br J Pharmacol 165:106-119.
25. Kawao N, Hiramatsu K, Inoi N, Kuroda R, Nishikawa H, Sekiguchi F, Kawa-bata A (2003) The PAR-1-activating peptide facilitates pepsinogen secretion in rats. Peptides 24:1449-1451.
26. Keep RF, Xi G, Hua Y, Hoff JT (2005) The deleterious or beneficial effects of different agents in intracerebral hemorrhage: think big, think small, or is hematoma size important? Stroke 36:1594-1596.
27. Kondo N, Ogawa M, Wada H, Nishikawa S (2009) Thrombin induces rapid disassembly of claudin-5 from the tight junction of endothelial cells. Exp Cell Res 315:2879-2887.
28. Liu DZ, Ander BP, Xu H, Shen Y, Kaur P, Deng W, Sharp FR (2010) Blood-brain barrier breakdown and repairbySrc after thrombin-induced injury. Ann Neurol 67:526-533.
29. Longa EZ, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91.
30. Lyden PD, Zivin JA, Chabolla DR, Jacobs MA, Gage FH (1992) Quantitative effects of cerebral infarction on spatial learning in rats. Exp Neurol 116:122-132.
31. Manoonkitiwongsa PS, Schultz RL, McCreery DB, Whitter EF, Lyden PD (2004) Neuroprotection of ischemic brain by vascular endothelial growth factor is critically dependent on proper dosage and may be compromised by angiogenesis. J Cereb Blood Flow Metab 24:693-702.
32. Mhatre M, Nguyen A, Kashani S, Pham T, Adesina A, Grammas P (2004) Thrombin, a mediator of neurotoxicity and memory impairment. Neu-robiol Aging 25:783-793.
33. Nakanishi-Matsui M, Zheng YW, Sulciner DJ, Weiss EJ, Ludeman MJ, Coughlin SR (2000) PAR3 is a cofactor for PAR4 activation by throm-bin. Nature 404:609-613.
34. Nishino A, Suzuki M, Ohtani H, Motohashi O, Umezawa K, Nagura H, Yoshimoto T (1993) Thrombin may contribute to the pathophysiology of central nervous system injury. J Neurotrauma 10:167-179.
35. Olson EE, Lyuboslavsky P, Traynelis SF, McKeon RJ (2004) PAR-1 deficiency protects against neuronal damage and neurologic deficits after unilateral cerebral hypoxia/ischemia. J Cereb Blood Flow Metab 24:964-971.
36. Olson ES, Aguilera TA, Jiang T, Ellies LG, Nguyen QT, Wong EH, Gross LA, Tsien RY (2009) In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer. Integr Biol (Camb) 1:382-393.
37. Olson ES, Jiang T, Aguilera TA, Nguyen QT, Ellies LG, Scadeng M, Tsien RY (2010) Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases. Proc Natl Acad Sci U S A 107:4311-4316.
38. Olson ES, Whitney MA, Friedman B, Aguilera TA, Crisp JL, Baik FM, Jiang T, Baird SM, Tsimikas S, Tsien RY, Nguyen QT (2012) In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity. Integr Biol (Camb) doi:10.1039/C2IB00161F.
39. Riek-Burchardt M, Striggow F, Henrich-Noack P, Reiser G, Reymann KG (2002) Increase of prothrombin-mRNA after global cerebral ischemia in rats, with constant expression of protease nexin-1 and protease-activated receptors. Neurosci Lett 329:181-184.
40. Strande JL, Hsu A, Su J, Fu X, Gross GJ, Baker JE (2007) SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts. Basic Res Cardiol 102:350-358.
41. Striggow F, Riek M, Breder J, Henrich-Noack P, Reymann KG, Reiser G (2000) The protease thrombin is an endogenous mediator of hippocam-pal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc Natl Acad Sci U S A 97:2264-2269.
42. Sugg RM, Pary JK, Uchino K, Baraniuk S, Shaltoni HM, Gonzales NR, Miku-lik R, Garami Z, Shaw SG, Matherne DE, Moyé LA, Alexandrov AV, Grotta JC (2006) Argatroban tPA stroke study: study design and results in the first treated cohort. Arch Neurol 63:1057-1062.
43. Tsopanoglou NE, Maragoudakis ME (1999) On the mechanism of thrombin-induced angiogenesis. Potentiation of vascular endothelial growth factor activity on endothelial cells by up-regulation of its receptors. J Biol Chem 274:23969-23976.
44. Vandenbroucke E, Mehta D, Minshall R, Malik AB (2008) Regulation of endothelial junctional permeability. Ann N Y Acad Sci 1123:134-145.
45. Vu TK, Hung DT, Wheaton VI, Coughlin SR (1991) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057-1068.
46. Whitney M, Crisp JL, Olson ES, Aguilera TA, Gross LA, Ellies LG, Tsien RY (2010) Parallel in vivo and in vitro selection using phage display identifies protease-dependent tumor-targeting peptides. J Biol Chem 285:22532-22541.
47. Xue M, Del Bigio MR (2001) Acute tissue damage after injections of throm-bin and plasmin into rat striatum. Stroke 32:2164-2169.
48. Yang S, Song S, Hua Y, Nakamura T, Keep RF, Xi G (2008) Effects of throm-bin on neurogenesis after intracerebral hemorrhage. Stroke 39:2079-2084.